US3671400A - Bacterial controls and preparation thereof - Google Patents
Bacterial controls and preparation thereof Download PDFInfo
- Publication number
- US3671400A US3671400A US882691A US3671400DA US3671400A US 3671400 A US3671400 A US 3671400A US 882691 A US882691 A US 882691A US 3671400D A US3671400D A US 3671400DA US 3671400 A US3671400 A US 3671400A
- Authority
- US
- United States
- Prior art keywords
- bacteria
- percent
- disc
- composition
- monosodium glutamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title description 4
- 241000894006 Bacteria Species 0.000 claims abstract description 65
- 108010010803 Gelatin Proteins 0.000 claims abstract description 33
- 229920000159 gelatin Polymers 0.000 claims abstract description 33
- 235000019322 gelatine Nutrition 0.000 claims abstract description 33
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 33
- 239000008273 gelatin Substances 0.000 claims abstract description 32
- 229920002491 Diethylaminoethyl-dextran Polymers 0.000 claims abstract description 27
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims abstract description 27
- 235000013923 monosodium glutamate Nutrition 0.000 claims abstract description 27
- 239000004223 monosodium glutamate Substances 0.000 claims abstract description 27
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims description 31
- 235000015097 nutrients Nutrition 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 14
- 230000035899 viability Effects 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 2
- 238000004886 process control Methods 0.000 claims description 2
- 230000004069 differentiation Effects 0.000 claims 1
- 238000010998 test method Methods 0.000 abstract description 6
- 239000013049 sediment Substances 0.000 abstract description 3
- 238000009631 Broth culture Methods 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 26
- 239000002609 medium Substances 0.000 description 9
- 230000000721 bacterilogical effect Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000191963 Staphylococcus epidermidis Species 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000001974 tryptic soy broth Substances 0.000 description 4
- 108010050327 trypticase-soy broth Proteins 0.000 description 4
- 108010065152 Coagulase Proteins 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229960002086 dextran Drugs 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- 241000588697 Enterobacter cloacae Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 241000588767 Proteus vulgaris Species 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- -1 e.g. Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229940007042 proteus vulgaris Drugs 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 239000007102 tryptic soy broth medium Substances 0.000 description 2
- WOLQREOUPKZMEX-BZSNNMDCSA-N (2s)-2-[[(4s)-4-[[(4s)-4-[[4-[(2-amino-4-oxo-1h-pteridin-6-yl)methylamino]benzoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C=C1 WOLQREOUPKZMEX-BZSNNMDCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101710167296 Arginine deiminase 2 Proteins 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 108010048581 Lysine decarboxylase Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 101710120433 Ornithine decarboxylase 2 Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- ZBCAZEFVTIBZJS-UHFFFAOYSA-M sodium;2-benzamidoacetate Chemical compound [Na+].[O-]C(=O)CNC(=O)C1=CC=CC=C1 ZBCAZEFVTIBZJS-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M45/00—Means for pre-treatment of biological substances
- C12M45/22—Means for packing or storing viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material
- G01N2496/25—Reference solutions for assays of biological material containing added polymers to stabilise biological material against degradation or maintain viscosity or density, e.g. gelatin, polyacrylamides or polyvinyl alcohol
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/873—Proteus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
- Y10S435/875—Pseudomonas aeruginosa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/882—Staphylococcus
- Y10S435/883—Staphylococcus aureus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/882—Staphylococcus
- Y10S435/884—Staphylococcus epidermidis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/885—Streptococcus
Definitions
- the laboratories In order to ensure that the tests as run in the laboratories are performing accurately and consistently, the laboratories must check their procedures and reagents with cultures of the specific bacteria being detected. Since these cultures have predictable biochemical properties, the laboratories are able to evaluate their procedures and reagents. In order to do this, the laboratories must acquire a set of cultures and perpetuate them. Since the cultures are generally rather unstable and must be subcultured frequently, an element of uncertainty is injected into the situation because each time an organism is subcultured, mutations may occur. Thus, the clinical bacteriologist requires a stable, readily available economic source of viable standard-reacting microorganisms.
- lyophilization The usual method of preserving bacteria by freeze-drying (lyophilization) is not suitable for routine quality control cultures because of the inconvenience and expense involved.
- a vial of lyophilized bacteria must be used immediately after reconstitution, but since the amount of inoculum obtained is small and adequate for a limited number of tests, the expense involved is prohibitive.
- the preparation of lyophilized cultures is difficult and expensive, therefore they are usually used to propagate a larger, fresh culture rather than being used directly in a bacteriological procedure.
- This invention relates to stable bacterial control discs suitable for direct use in bacteriological tests as well as methods for preparing and using the discs.
- suitable bacterial controls can be formed in stable form as discs by vacuum desiccation of bacterial cultures suspended in a nutrient medium containing a nutrient gelatin and materials which stabilize the viability of the bacteria. Controls for other microorganisms such as fungi can also be formed in a similar manner. This invention, however, is directed to bacterial controls.
- the type of bacteria which are particularly suitable for use in this invention are those non-spore forming bacteria which remain viable upon desiccation and are stable under conditions of accelerated stability tests. While many bacteria are suitable under these criteria, those which are preferred are the common gram negative and gram positive bacteria generally tested for by the clinical bacteriologist. Examples of some suitable organisms are Staphylococcus aureus, Staphylococcus epidermidis, Enterobacter cloacae, Salmonella typhimurium, Proteus vulgaris, Escherichia coli, Pseudomonas aeruginosa and Streptococcus pyogenes and the like.
- the suspending medium which has been found to be most efficacious and is thus preferred contains about 90 percent to about 97 percent by weight of a nutrient gelatin, about 0.005 percent to about 0.015 percent by weight of diethylaminoethyl dextran and about 2 percent to about percent by weight of monosodium glutamate.
- the latter two materials stabilize the viability of the bacteria.
- the invention comprehends the use of other materials which stabilize the viability of the bacteria.
- the diethylaminoethyl dextran and monosodium glutamate can be replaced by an equal total amount of either glucose, sucrose, lactose, mannitol or polyvinylpyrrolidone.
- dextran sulfate or dextran can be used to replace the diethylaminoethyl dextran.
- concentration of the nutrient gelatin is increased to up to about 99.1 to about 99.5 percent, then all the previously mentioned stabilizers can be replaced by cysteine, thiourea, glutathione and monothioglycerol.
- the nutrient gelatins which are suitable for use in the compositions of this invention are generally commercially available materials, e.g., Bacto Nutrient Gelatin (Difco Co.) and Nutrient Gelatin (Baltimore Biological Laboratory). Any other commercially available nutrient gelatin is suitable provided it is amenable to dessication and forms discs with the required physical properties. While the amount of nutrient gelatin can vary between about to about 97 percent by weight of the suspending medium, it is preferred to use compositions containing about 96 to 97 percent. More would result in poor bacterial stability and less would result in discs with undesirable physical properties.
- the amount of diethylaminoethyl dextran, dextran sulfate or dextran used in combination with monosodium glutamate should be sufi'rcient to provide stability to the viability of the bacteria, usually about 0.005 to 0.015 percent by weight is sufficient with about 0.01 percent preferred. It is preferred to use diethylaminoethyl dextran.
- the remainder of the composition when a dextran is used is monosodium glutamate which should be present in a concentration of from about 2 to 10 percent, with about 3 percent preferred.
- the bacterial control discs are prepared under aseptic conditions, to avoid contamination.
- the discs are prepared by desiccating, under vacuum, droplets of the suspending medium containing the bacteria.
- the droplets, when thus treated become transformed into firm discs.
- the discs are approximately circular in shape and weight from about 2.8 to about 4.0 mg. This shape and size is determined by the size of the droplets and the surface upon which they are dried. Preferably discs weighing about 3.2 mg. are formed.
- the term disc is used to mean any dried droplet, formed according to this invention.
- a sterile non-adhering surface e. g., a waxed Petri dish, for easy removal of the resulting discs.
- the droplets on the sterile non-adhering surface are dried under a vacuum of about 500-600 mm. Hg. at room temperature. This can be accomplished in a desiccator jar containing CaSO and usually takes about 7-2 hours. Other conventional vacuum drying means and conditions can be used with equivalent results.
- the discs which are formed can be stored in small sterile screw-capped vials containing a desiccant, e.g., silica gel, CaCl CaSO Other sterile containers can be used, however, the vials are convenient for labelling, shipping, storage and use in the laboratory.
- a desiccant e.g., silica gel, CaCl CaSO
- Other sterile containers can be used, however, the vials are convenient for labelling, shipping, storage and use in the laboratory.
- the organism is prepared for desiccation by growing the organism in a suitable broth, e.g., Tryptic Soy Broth medium, for about 15-24 hours at about 30-40C., preferably 37C.
- a suitable broth e.g., Tryptic Soy Broth medium
- the culture is then centrifuged and the bacterial sediment which results is then suspended in the gelatin suspending medium and dispensed in drops to a non-adhering surface and vacuum desiccated.
- the discs which result from the aforementioned process contain about 10 to 10 viable organisms per disc and the viability of the organism is protected. without allowing its biochemical characteristics to be altered. This stability is evidenced by an accelerated stability test wherein the viability of the organism was retained after the discs were subjected to temperatures of 100C. for from 5 hours to 7 hours. This effeet is significant since the same bacteria would ordinarily be killed by such temperatures.
- the bacteria are excellent for control purposes and this invention permits laboratories to I I l I I l I l I l I l I l I egfw ofieefiw m I I I I I l I E sfitg m I I l l l l I Q A+v I I I l EEE $295 I I q I I I I n A+V l I 55 5.53 sm im I 4 I A+v N hi I 88 E EEEN I d I I I l I I I a A+v l l I I I SEU Q QGQQS EB W I 1 l l I I I A+v I l I 33.5: u ufigaiw 2 3m w 3: 25 .5mm 30: 3.5 3 3 3 5 5 5 3 8a 85 S 303 32: x E -E m E 2G -SEQ 230 24 64 3.
- the proper organism In order to utilize the bacteria in the discs as a control for a diagnostic test, the proper organism must be selected. It is preferable to select one which is negative for the test as well as one which is positive.
- the disc containing the organism is then either added directly to the test media or is placed in a suitable liquid growth medium, e.g., Tryptic Soy Broth and incubated for about 2 to 24 hours. In the latter procedure, one or more loopfuls of the suspension of bacteria in the Broth can then be used in the test procedure to determine its sufficiency and accuracy. In the former direct procedure, the discs are used directly in the test procedure to determine its sufficiency and accuracy.
- Table I lists some of the primary identification tests for bacteria and indicates the reaction of the control organisms.
- Table II lists some of the carbohydrate fermentation reactions of the control organisms.
- the following table contains a tabulation of the recommended organisms for positive and negative control of bacteriological tests.
- Ornithine decarboxylase 2 3 I0.Arginine dihydrolase 2 3 l l. Catalase any none 12. Coagulase 4 5 13. KCN 2 1 I4. DNAase 4 5 I5. Glucose fennentation I 7" l6. Lactose fermentation l 3 I7. MannitoI fermentation 4 5 l8. fihemolysis on blood agar 8 5 l9. Bacitracin disc 8 20. Sodium hippurate 4 8 Organism No. 7 is negative for fermentation of glucose but will degrade this carbohydrate oxidatively.
- the identified organism is grown in 10 ml. Tryptic Soy Broth medium for 16 to 18 hours at 37.
- the Tryptic Soy Broth is composed of 17 grams of pancreatic digest of casein. 3 grams of soy bean peptone, 5 grams of sodium chloride, 2.5 grams of dipotassium phosphate, 2.5 grams of glucose and 1,000 ml. of distilled water. The final pH is about 7.3.
- the resulting culture is centrifuged and the supernatant liquid is decanted and discarded.
- the remaining bacterial sediment is suspended in 4 ml. of a sterile mixture consisting of 96.99 percent nutrient gelatin; 0.01 percent diethylaminoethyl dextran and 3 percent monosodium glutamate, by weight.
- the suspended organisms are aseptically dispensed with a Pasteur pipette in drops of about 0.02-0.05 ml. onto a sterile waxed Petridish.
- the dishes containing the droplets of organisms are placed in a desiccator jar containing CaSO, and the jar is evacuated to 500-600 mm. Hg. and allowed to stand at room temperature, about 2025 for 72 hours.
- the droplets become transformed into firm discs when dried.
- the discs are aseptically dislodged from the waxed surface and placed in small sterile screw-capped vials containing a silica gel desiccant. About 30 discs are put into each vial.
- the vials are suitable for use as a kit and can be transported or stored.
- EXAMPLE 2 This example illustrates the use of the discs.
- a. Indirect Method A disc is aseptically removed from a vial with sterile forceps and placed in a sterile screw-capped tube containing 2 ml. of sterile Tryptic Soy Broth and incubated at 37 for l-2 hours. A suspension of viable organisms is formed.
- One or two loopfuls of the suspension are used to inoculate the appropriate biochemical test media, depending on the nature of the specific organism being identified and test being controlled. The results are then observed and the quality of the test determined.
- Direct Method A disc is added directly to the test medium as, for example, in the following coagulase test:
- Two discs, one with Staphylococcus aureus and one with Staphylococcus epidermidis are placed in separate test tubes containing rabbit plasma.
- the bacteriologist can determine if his coagulase test procedure is correct and performed properly. Analogously, the procedures for the other tests described herein which are directed to detecting these and other organisms can be evaluated.
- EXAMPLE 3 The stability of the organisms prepared in the discs is deter mined by an accelerated stability test calculated to detect the viability of the organism and conducted as follows:
- a composition suitable for forming by vacuum desiccation at ambient temperature into a stable disc for preserving bacteria comprising a nutrient gelatin and materials which stabilize the viability of the bacteria wherein said materials are diethylaminoethyl dextran and monosodium glutamate.
- composition of-claim 1 containing on a weight basis from about 90 to about 97 percent nutrient gelatin, from about 0.005 to about 0.015 percent diethylaminoethyl dextran and the remainder monosodium glutamate.
- composition of claim 1 containing on a weight basis 96.99 percent nutrient gelatin, 0.01 percent diethylaminoethyl dextran and 3 percent monosodium glutamate.
- a stable dry disc prepared by vacuum desiccation at ambient temperature containing bacteria and a suspending medium for said bacteria comprising nutrient gelatin and materials which stabilize the viability of said bacteria wherein said materials are diethylaminoethyl dextran and monosodium glutamate.
- the disc of claim 4 containing between about 10 and I0 viable bacteria per disc.
- suspending medium contains on a dry weight basis about 96.99 percent mutrient gelatin, about 0.01 percent diethylaminoethyl dextran and about 3.0 percent monosodium glutamate.
- a method of producing a stable disc for preserving bacteria which comprises adding bacteria to be preserved to the composition of claim 1 and vacuum desiccating the mixture at ambient temperature on a sterile, non-adhering, supporting. member.
- a method of producing a stable disc for preserving bacteria which comprises adding bacteria to be preserved to the composition of claim 2 and vacuum desiccating the mixture at ambient temperature on a sterile, non-adhering, supporting member.
- a method of producing a stable disc for preserving bacteria which comprises adding bacteria to-be preserved to the composition of claim 3 and vacuum desiccating the mixture at ambient temperature on a sterile, non-adhering, supporting member.
- a method of preserving identified bacteria which comprises forming a composition containing said identified bacteria and a suspending medium for said bacteria comprising nutrient gelatin and materials to stabilize the viability of said bacteria wherein said materials are diethylaminoethyl dextran and monosodium glutamate and then vacuum desiccating at ambient temperature discrete droplets of the composition on a sterile non-adhering supporting surface.
- composition before desiccation comprises identified viable bacteria, about 90 to about 97 percent by weight nutrient gelatin, about 0.005 to about 0.015 percent by weight diethylaminoethyl dextran and the remainder monosodium glutamate.
- a method of evaluating the accuracy of biochemical bacterial difierentiation and identification procedures and reagents which comprises using identified bacteria in the form of a stable gelatin disc as a process control, by observing the activity thereof with said procedures and reagents wherein said disc is prepared by vacuum desiccation at ambient tempera- .ture from a composition comprising, prior to desiccation, said bacteria, nutrient gelatin, diethylaminoethyl dextran and monosodium glutamate.
- a diagnostic reagent kit comprising a closed aseptic container having therein stable preserved identified viable bacteria in discs comprising said bacteria, nutrient gelatin, diethylaminoethyl dextran and monosodium glutamate, said discs weighing about 2.8 to about 4.0 mg. and wherein said composition prior to desiccation at ambient temperature thereof comprises said bacteria, about 90 to about 97 percent by weight nutrient gelatin, about 0.005 to about 0.015 percent by weight diethylaminoethyl dextran and about 2 to 10 percent by weight of monosodium glutamate.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Sustainable Development (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88269169A | 1969-12-05 | 1969-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3671400A true US3671400A (en) | 1972-06-20 |
Family
ID=25381135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US882691A Expired - Lifetime US3671400A (en) | 1969-12-05 | 1969-12-05 | Bacterial controls and preparation thereof |
Country Status (9)
Country | Link |
---|---|
US (1) | US3671400A (da) |
BE (1) | BE759858A (da) |
CA (1) | CA937171A (da) |
CH (1) | CH557425A (da) |
DK (1) | DK127009B (da) |
FR (1) | FR2072920A5 (da) |
GB (1) | GB1282378A (da) |
NL (1) | NL148937B (da) |
SE (1) | SE384692B (da) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3936355A (en) * | 1973-11-12 | 1976-02-03 | The Regents Of The University Of California | Microorganism growth media and the stabilization thereof |
US4038143A (en) * | 1973-10-29 | 1977-07-26 | The Regents Of The University Of Michigan | Test kit for the genetic detection of microorganisms |
US4672037A (en) * | 1983-11-03 | 1987-06-09 | American Type Culture Collection | Method of culturing freeze-dried microorganisms |
US4879239A (en) * | 1983-11-03 | 1989-11-07 | American Type Culture Collection | Method of culturing freeze-dried microorganisms and resultant preparation |
US5155039A (en) * | 1991-07-22 | 1992-10-13 | Chrisope Technologies, Inc. | Apparatus for methods for preserving, transporting storing, re-hydrating and delivering viable micro-organisms |
US5279964A (en) * | 1984-01-10 | 1994-01-18 | Chrisope Technologies, Inc. | Storable inoculation device containing stabilized microorganisms |
US5856172A (en) * | 1997-01-03 | 1999-01-05 | Quality Technologies, Llc | Preservation of microorganisms in a vial with a cap comprising an immobilized desiccant |
US20040101972A1 (en) * | 2002-11-25 | 2004-05-27 | Agdia, Inc. | Controls and standards for assays and method for manufacture thereof |
US20060040340A1 (en) * | 2004-08-17 | 2006-02-23 | Nathan Greene | Microorganism specimen storage, hydrating, transfer and applicator device |
US20070072293A1 (en) * | 2005-09-26 | 2007-03-29 | Manoj Kole | Process for stabilization of bacterial cells |
US8221705B2 (en) | 2007-06-21 | 2012-07-17 | Gen-Probe, Incorporated | Receptacles for storing substances in different physical states |
US11530379B2 (en) | 2020-07-20 | 2022-12-20 | Stratix Labs Corporation | Devices and methods for inoculating a target |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2181543A1 (en) * | 1972-04-24 | 1973-12-07 | Bourgeay Jean Pierre | Bacteria identification - using electronic logic circuit to compare sample characteristics with standards |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340156A (en) * | 1964-04-28 | 1967-09-05 | Novo Terapeutisk Labor As | Purification of plasminogen |
-
0
- BE BE759858D patent/BE759858A/xx unknown
-
1969
- 1969-12-05 US US882691A patent/US3671400A/en not_active Expired - Lifetime
-
1970
- 1970-11-18 CA CA098430A patent/CA937171A/en not_active Expired
- 1970-11-18 CH CH1701070A patent/CH557425A/xx not_active IP Right Cessation
- 1970-12-03 NL NL707017686A patent/NL148937B/xx unknown
- 1970-12-04 GB GB57728/70A patent/GB1282378A/en not_active Expired
- 1970-12-04 DK DK619370AA patent/DK127009B/da unknown
- 1970-12-04 FR FR7043711A patent/FR2072920A5/fr not_active Expired
- 1970-12-04 SE SE7016451A patent/SE384692B/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340156A (en) * | 1964-04-28 | 1967-09-05 | Novo Terapeutisk Labor As | Purification of plasminogen |
Non-Patent Citations (1)
Title |
---|
Hockenhull, editor, Progress in Industrial Microbiology Vol. IV: 191 193, 201 204, and 211 212. (1963). * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4038143A (en) * | 1973-10-29 | 1977-07-26 | The Regents Of The University Of Michigan | Test kit for the genetic detection of microorganisms |
US3936355A (en) * | 1973-11-12 | 1976-02-03 | The Regents Of The University Of California | Microorganism growth media and the stabilization thereof |
US4672037A (en) * | 1983-11-03 | 1987-06-09 | American Type Culture Collection | Method of culturing freeze-dried microorganisms |
US4879239A (en) * | 1983-11-03 | 1989-11-07 | American Type Culture Collection | Method of culturing freeze-dried microorganisms and resultant preparation |
US5279964A (en) * | 1984-01-10 | 1994-01-18 | Chrisope Technologies, Inc. | Storable inoculation device containing stabilized microorganisms |
US5155039A (en) * | 1991-07-22 | 1992-10-13 | Chrisope Technologies, Inc. | Apparatus for methods for preserving, transporting storing, re-hydrating and delivering viable micro-organisms |
US5856172A (en) * | 1997-01-03 | 1999-01-05 | Quality Technologies, Llc | Preservation of microorganisms in a vial with a cap comprising an immobilized desiccant |
US6057151A (en) * | 1997-01-03 | 2000-05-02 | Quality Technologies, Llc | Preservation of microorganisms in a vial with a cap comprising an immobilized desiccant |
US20040101972A1 (en) * | 2002-11-25 | 2004-05-27 | Agdia, Inc. | Controls and standards for assays and method for manufacture thereof |
US6927062B2 (en) | 2002-11-25 | 2005-08-09 | Agdia, Inc. | Controls and standards for assays and method for manufacture thereof |
US20060040340A1 (en) * | 2004-08-17 | 2006-02-23 | Nathan Greene | Microorganism specimen storage, hydrating, transfer and applicator device |
US7645608B2 (en) | 2004-08-17 | 2010-01-12 | Pml Microbiologicals, Inc. | Microorganism specimen storage, hydrating, transfer and applicator device |
US20070072293A1 (en) * | 2005-09-26 | 2007-03-29 | Manoj Kole | Process for stabilization of bacterial cells |
US8221705B2 (en) | 2007-06-21 | 2012-07-17 | Gen-Probe, Incorporated | Receptacles for storing substances in different physical states |
US10688458B2 (en) | 2007-06-21 | 2020-06-23 | Gen-Probe Incorporated | System and method of using multi-chambered receptacles |
US10744469B2 (en) | 2007-06-21 | 2020-08-18 | Gen-Probe Incorporated | Multi-chambered receptacles |
US11235295B2 (en) | 2007-06-21 | 2022-02-01 | Gen-Probe Incorporated | System and method of using multi-chambered receptacles |
US11235294B2 (en) | 2007-06-21 | 2022-02-01 | Gen-Probe Incorporated | System and method of using multi-chambered receptacles |
US11530379B2 (en) | 2020-07-20 | 2022-12-20 | Stratix Labs Corporation | Devices and methods for inoculating a target |
US12098357B2 (en) | 2020-07-20 | 2024-09-24 | Stratix Labs Corporation | Devices and methods for inoculating a target |
Also Published As
Publication number | Publication date |
---|---|
NL7017686A (da) | 1971-06-08 |
GB1282378A (en) | 1972-07-19 |
CA937171A (en) | 1973-11-20 |
CH557425A (de) | 1974-12-31 |
DE2059788B2 (de) | 1976-01-15 |
FR2072920A5 (da) | 1971-09-24 |
BE759858A (fr) | 1971-06-04 |
DE2059788A1 (de) | 1971-06-09 |
SE384692B (sv) | 1976-05-17 |
DK127009B (da) | 1973-09-10 |
NL148937B (nl) | 1976-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
North Jr | Lactose Pre-enrichment Method for Isolation of Salmonella from Dried Egg Albumin: Its Use in a Survey of Commercially Produced Albumen | |
US3671400A (en) | Bacterial controls and preparation thereof | |
US5856172A (en) | Preservation of microorganisms in a vial with a cap comprising an immobilized desiccant | |
Borek et al. | Studies on a mutant of Escherichia coli with unbalanced ribonucleic acid synthesis | |
US4245043A (en) | Negative control media device and method for microbiologic biochemical tests | |
EP0145197B1 (en) | Method of culturing freeze-dried microorganisms | |
Green et al. | A differential procedure applicable to bacteriological investigation in brewing | |
US6867015B1 (en) | Rapid microbiological test for the detection of antibacterial compounds | |
US5279964A (en) | Storable inoculation device containing stabilized microorganisms | |
US4879239A (en) | Method of culturing freeze-dried microorganisms and resultant preparation | |
Previte | Radiometric detection of some food-borne bacteria | |
Taylor et al. | Isolation of Salmonellae from Food Samples: I. Factors Affecting the Choice of Media for the Detection and Enumeration of Salmonella | |
Babu et al. | Evaluation of twenty-three blood culture media | |
Zapatka et al. | Neutralization of the bactericidal effect of cocoa powder on salmonellae by casein | |
Kleck et al. | Production of Thermostable Hemolysin by Cultures of" Staphylococcus epidermidis" | |
CA2055973C (en) | Fastidious organism supplement | |
US4246349A (en) | Stabilization of immobilized bacteria | |
Doern | In vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations | |
US4250264A (en) | Growth limiting media | |
Henrichsen et al. | An evaluation of the effects of a high concentration of sucrose in blood culture media | |
EP0073089B1 (en) | Culture medium and method for culturing body fluids containing antimicrobials | |
US4217411A (en) | Novel enrichments for blood culture media | |
US3951747A (en) | Lyophilized media | |
US4444883A (en) | Method for the isolation and presumptive diagnosis of Bacillus cereus and tellurite medium therefor | |
Nimmo et al. | Selection of media for the isolation of common bacterial L-phase organisms from a clinical specimen |